KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Sep 16, 2026 - 3:59PM >>  ABB India 6982  [ -0.39% ]  ACC 1222.95  [ -0.04% ]  Ambuja Cements 382  [ -0.03% ]  Asian Paints 2419  [ 0.46% ]  Axis Bank 1243.95  [ 1.93% ]  Bajaj Auto 11590  [ 1.49% ]  Bank of Baroda 234.5  [ 0.67% ]  Bharti Airtel 1837  [ 0.38% ]  Bharat Heavy 410  [ -0.97% ]  Bharat Petroleum 302.65  [ 1.22% ]  Britannia Industries 5006.5  [ 1.12% ]  Cipla 1359.75  [ -0.09% ]  Coal India 421.9  [ 0.69% ]  Colgate Palm 1864  [ 2.14% ]  Dabur India 383  [ -0.52% ]  DLF 623  [ 0.32% ]  Dr. Reddy's Lab. 1145.25  [ -0.39% ]  GAIL (India) 171.05  [ 0.32% ]  Grasim Industries 3189.95  [ 0.00% ]  HCL Technologies 1251.15  [ -0.31% ]  HDFC Bank 722.4  [ 0.75% ]  Hero MotoCorp 5248.95  [ 1.31% ]  Hindustan Unilever 1963.5  [ 1.21% ]  Hindalco Industries 973.2  [ 1.32% ]  ICICI Bank 1359  [ 0.52% ]  Indian Hotels Co. 713  [ -0.34% ]  IndusInd Bank 945.05  [ -1.31% ]  Infosys 1060.65  [ -1.43% ]  ITC 264.35  [ 2.46% ]  Jindal Steel 1104.4  [ 0.80% ]  Kotak Mahindra Bank 414.9  [ 1.29% ]  L&T 3819.5  [ -0.79% ]  Lupin 2047.2  [ -0.40% ]  Mahi. & Mahi 3073.95  [ 1.45% ]  Maruti Suzuki India 12189.8  [ -0.61% ]  MTNL 23.78  [ 0.21% ]  Nestle India 1386  [ 2.15% ]  NIIT 85.55  [ -2.06% ]  NMDC 80.35  [ -0.42% ]  NTPC 327  [ -0.91% ]  ONGC 236.6  [ 0.47% ]  Punj. NationlBak 116.6  [ 2.10% ]  Power Grid Corpn. 263.5  [ 0.00% ]  Reliance Industries 1241.4  [ 0.44% ]  SBI 991.1  [ 2.24% ]  Vedanta 256  [ -0.47% ]  Shipping Corpn. 268.25  [ -0.13% ]  Sun Pharmaceutical 1853.5  [ 1.01% ]  Tata Chemicals 732.1  [ -0.33% ]  Tata Consumer 1003.3  [ 2.27% ]  Tata Motors Passenge 301.05  [ -0.64% ]  Tata Steel 182.85  [ -0.30% ]  Tata Power Co. 361  [ -0.63% ]  Tata Consult. Serv. 2191.5  [ -2.60% ]  Tech Mahindra 1555.15  [ -1.26% ]  UltraTech Cement 10720  [ -0.28% ]  United Spirits 1388.8  [ 1.61% ]  Wipro 166.7  [ -1.85% ]  Zee Entertainment 79.58  [ 2.82% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

RELIC TECHNOLOGIES LTD.

16 September 2026 | 04:01

Industry >> Finance & Investments

Select Another Company

ISIN No INE452B01013 BSE Code / NSE Code 511712 / RELICTEC Book Value (Rs.) 33.80 Face Value 10.00
Bookclosure 30/09/2024 52Week High 91 EPS 0.00 P/E 0.00
Market Cap. 25.84 Cr. 52Week Low 52 P/BV / Div Yield (%) 2.12 / 0.00 Market Lot 1.00
Security Type Other

DIRECTOR'S REPORT

You can view full text of the latest Director's Report for the company.
Year End :2026-03 

On behalf of the Board of Directors (‘the Board’), it is our pleasure to present the 35th Annual Report of the Company along with the Audited Financial Statements (standalone and consolidated) and Auditors Report for the Financial Year ended March 31,2026 (“FY 2025-26”).

1. Key Financial Highlights (Standalone and Consolidated)

Financial highlights of the Company for Financial Year 2025-26 as compared to the preceding financial year, on standalone and consolidated basis are given below.

(INR in lacs)

Particulars

Consolidated

Standalone

For the financial year ended 31/03/2026

For the financial year ended 31/03/2025

For the financial year ended 31/03/2026

For the financial year ended 31/03/2025

Net Sales /Income from Business Operations

267.08

197.59

0.00

166.32

Other Income

74.37

6.92

130.18

10.03

Total Income

341.45

204.51

130.18

176.35

Profit / (loss) after depreciation and Interest

(689.04)

(147.00)

59.23

(170.13)

Exceptional Item

0.00

0.00

0.00

0.00

Less: Current Income Tax

4.82

0.00

4.82

0.00

Less: Previous year adjustment of Income Tax

(0.34)

0.00

(0.34)

0.00

Less: Deferred Tax

0.97

1.74

0.55

1.74

Net Profit after Tax

(694.49)

(148.74)

54.20

(171.87)

Total Comprehensive Income

(692.94)

(151.05)

54.20

(174.18)

Net Profit after dividend and Tax

(148.74)

(148.74)

54.20

(171.87)

Earnings per share (Basic) in Rs. Actual

(13.19)

(4.13)

1.03

(4.77)

Earnings per Share (Diluted) in Rs. Actual

(13.19)

(4.13)

1.03

(4.77)

2. State of Company’s affairs

The Audited Standalone and Consolidated Financial Statements of your Company for FY 2025-26 are prepared in compliance with the applicable provisions of the Companies Act, 2013 (‘the Act’), Indian Accounting Standards (‘Ind AS’) and the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (‘SEBI Listing Regulations’).

In accordance with the provisions of Section 129(3) of the Act, the audited consolidated financial statements are also provided in the Annual Report.

During the Financial Year 2025-26, the Company did not generate any revenue from operations on a standalone basis, as compared to revenue from operations of INR 166.32 lakhs in the previous Financial Year 2024-25. Despite the absence of operational revenue during the year, the Company reported a net profit of INR 54.20 lakhs for FY 2025-26, as against a net loss of INR 171.87 lakhs in FY 2024-25.

On a consolidated basis, the Company’s revenue from operations for the Financial Year 2025-26 stood at INR 267.08 lakhs as compared to INR 197.59 lakhs in the previous Financial Year 2024-25. However, the Company incurred a net loss of INR 694.49 lakhs during FY 2025-26, as against a net loss of INR 148.74 lakhs in FY 2024-25.

The Company’s performance has been discussed in detail in the “Management Discussion and Analysis Report” which forms a part of this Report.

3. Business Operations & Future Outlook/ Change in nature of business

The Members of the Company, at the 34th Annual General Meeting held on 29th August, 2025, approved the alteration of the Object Clause of the Memorandum of Association of the Company to carry out of the business of pharmaceuticals and wellness products. The alteration was carried out to enable the Company to undertake its revised business activities in line with its strategic objectives. However, during the year the Company could not commence any activities relating to the said new business due to procedural and licensing requirements. Accordingly, during the year under review, there was no revenue from operations. The company generated other income in view of the investment held.

4. Dividend

Although the Company has reported a profit during the Financial Year 2025-26, the Board of Directors has decided not to recommend any dividend for the year in order to conserve resources and strengthen the Company’s financial position.

5. Transfer to Reserves

The Company does not propose to transfer any amount to the General Reserve for the Financial Year 2025-26.

6. Share Capital

A. Authorised Share Capital

There was no change in the Authorised Share Capital of the Company during the Financial Year 202526. As on 31st March, 2026, the Authorised Share Capital of the Company stood at Rs. 10,00,00,000 (Rupees Ten Crores only), divided into 1,00,00,000 equity shares of Rs. 10/- each.

B. Changes in Issued, Subscribed and Paid-up Share Capital

During the Financial Year 2025-26, pursuant to the approval of the Members at the Extra-Ordinary General Meeting held on 18th March, 2025, the Company undertook the following allotments on a preferential basis in accordance with the applicable provisions of the Companies Act, 2013 and the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018:

- On 5th April, 2025, the Board of Directors, by way of Circular Resolution, allotted 15,50,000 equity shares of face value of Rs. 10/- each to certain Non-Promoter Investors.

- On 5th April, 2025, the Board of Directors, by way of Circular Resolution, also allotted 4,41,164 fully convertible warrants of face value of Rs. 10/- each to persons belonging to the Promoter and NonPromoter Group.

- Subsequently, on 13th December, 2025, the Company allotted 4,41,164 equity shares of face value of Rs. 10/- each upon conversion of the aforesaid fully convertible warrants, in accordance with the terms of issue and the applicable provisions of law.

Consequent to the aforesaid allotments, the Issued, Subscribed and Paid-up Equity Share Capital of the Company as on 31st March, 2026 stood at Rs. 5,59,11,640/- (Rupees Five Crores Fifty-Nine Lakhs Eleven Thousand Six Hundred Forty only), divided into 55,91,164 equity shares of Rs. 10/- each.

C. Employee Stock Option Scheme

During the Financial Year 2025-26, the Board of Directors approved the Employee Stock Option Scheme (“ESOP Scheme”), subject to the approval of the Members of the Company, in accordance with the applicable provisions of the Companies Act, 2013 and the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

A Special Resolution seeking the approval of the Members for the proposed ESOP Scheme forms part of the Notice convening the ensuing Annual General Meeting.

7. Adequacy of Internal Financial Controls with Reference to the Financial Statements

The Board has adopted systems, policies and procedures for efficient conduct of business, operations, safeguarding its assets and prevention of frauds. This ensures accuracy and completeness of accounting records and its timely preparation.

8.

Subsidiaries, Associates and Joint Ventures

Your Company has following subsidiaries as on March 31,2026:

Sr. No.

Name of the Subsidiary Companies

Percentage holding (in %)

1.

Relic Pharma Limited

99.93%

2.

Truhealthy Wellness Private Limited (w.e.f. 6th March 2025)

69.50%

Your Board reviewed the affairs of subsidiary and there has been no material change in the nature of the business of such subsidiary.

There are no associate companies or joint venture companies within the meaning of section 2(6) of the Companies Act, 2013 (“Act”).

In accordance with the requirements of Section 129(3) of the Companies Act, 2013, the consolidated financial statements of the Company and all its subsidiaries are prepared in accordance with the provisions as specified in the Companies (Accounts) Rules, 2014, form part of the Annual Report. Further, a statement containing the salient features of the financial statement of the Company’s subsidiaries in the prescribed Form AOC-1 is attached as “Annexure-I” to the Board’s Report. This statement also provides the details of the performance and financial position of each subsidiary.

In accordance with Section 136 of the Companies Act, 2013, the audited financial statements and related information of the subsidiaries, where applicable, will be available for inspection upon request. These will also be available on the Company’s website at https://relictechnologies.in/.

9. Particulars of Loans, Guarantees or Investments

Details of Loans, Guarantees and Investments covered under the provisions of Section 186 of the Act are given in the notes to the financial statements. The Company is in compliance of applicable provision of Section 186 of the Companies Act, 2013.

10. Corporate Governance and Additional Shareholders’ Information

The Company is exempted under Regulation 15(2)(a) of Chapter IV of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Hence, the Company is not required to comply with the provisions of regulations 17, 17A, 18, 19, 20, 21,22, 23, 24, 24A, 25, 26, 26A, 27 and clauses (b) to (i) and (t) of subregulation (2) of regulation 46 and para C, D and E of Schedule V of the SEBI Listing Regulations, 2015.

Therefore, the Corporate Governance Report is not required to be annexed with this report.

11. Management Discussion and Analysis

A detailed Report on the Management Discussion and Analysis in terms of the provisions of Regulation 34 of the SEBI (Listing Regulations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), is provided separately chapter in the Annual Report.

12. Board of Directors and Key Management Personnel Appointment/ Re-appointment of Directors

During the Financial Year 2025-26, the following changes took place in the composition of the Board of Directors and Key Managerial Personnel of the Company:

• Based on the recommendation of the Nomination and Remuneration Committee (“NRC”) and pursuant to the provisions of Section 161 of the Companies Act, 2013 (“the Act”), the Board of Directors appointed Mr. Karthik Iyer (DIN: 08216928) as an Additional Director and subsequently appointed as Executive Director with effect from 27th May, 2025. Subsequently, the Members at the 34th Annual General Meeting held on 29th August, 2025 approved his appointment as an Executive Director, liable to retire by rotation.

• Based on the recommendation of the NRC and pursuant to the provisions of Sections 149, 150, 152 and 161 of the Act read with Schedule IV thereto and the applicable SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board appointed Ms. Neha Anant Thakore (DIN: 00893957) as an Additional Director (Non-Executive, Independent Director) with effect from 30th July, 2025. The Members approved her appointment as an Independent Director for a term of five consecutive years from 30th July, 2025 to 29th July, 2030. She is not liable to retire by rotation.

• Mr. Baijoo Madhusudan Raval was appointed as the Chief Financial Officer of the Company with effect from 10th May, 2025.

• Based on the recommendation of the NRC, Mr. Baijoo Madhusudan Raval (DIN: 00429398) was reappointed as the Whole-time Director of the Company for a period of two years with effect from 1st April, 2025 and shall be liable to retire by rotation.

• Ms. Radhika Shriram was appointed as an Additional Director (Non-Executive, Non-Independent Director) with effect from 13th December, 2025. She holds office up to the date of the ensuing Annual General Meeting and, being eligible, has offered herself for appointment as a Director. The Board recommends her appointment.

• Mr. Mukesh Jugaldas Desai, Non-Executive Independent Director, resigned from the Board with effect from 30th July, 2025.

• Ms. Nehal Mishra resigned as the Company Secretary and Compliance Officer with effect from 5th May, 2025.

• Ms. Anita Amitkumar Gupta was appointed as the Company Secretary and Compliance Officer with effect from 1st August, 2025.

The Board places on record its sincere appreciation for the valuable guidance and contributions made by Mr. Mukesh Jugaldas Desai during his tenure as an Independent Director.

In accordance with the provisions of Section 152 of the Act and the Articles of Association of the Company, Mr. Kunal Gandhi (DIN: 01516156) retires by rotation at the ensuing Annual General Meeting and, being eligible, has offered himself for re-appointment. The Board recommends his re-appointment.

Subsequent to the close of the Financial Year:

Ý Mr. Karthik Iyer (DIN: 08216928) resigned as Executive Director of the Company with effect from 13th June, 2026.

Ý Mr. Sachin Srivastava was appointed as an Additional Director and subsequently as the Whole-time Director and Chief Executive Officer of the Company with effect from 13th June, 2026, subject to the approval of the Members at the ensuing Annual General Meeting.

13. Declaration by Independent Directors

The Company has received declarations from all the Independent Directors confirming that they meet with the criteria of independence as prescribed under Section 149(6) of the Act and Regulation 16(1)(b) of the SEBI Listing Regulations. There has been no change in the circumstances affecting their status as Independent Directors of the Company and in the opinion of the Board, the Independent Directors fulfil the conditions specified under the Act and the Listing Regulations and are Independent of the management.

14. Board Meetings:

During the Financial year 2025-26, Seven (7) meetings of Board of Directors were held. The intervening gap between two consecutive meetings was within the period prescribed under the Companies Act 2013 and Secretarial Standards on Board Meetings as amended from time to time. The Board Meetings were held on 10/05/2025, 27/05/2025, 26/07/2025, 30/07/2025, 08/11/2025, 13/12/2025 and 12/02/2026. Details of meetings of the Board are given below:

S. No.

Name of Directors

No. of Meetings

Entitled to attend

Attended

1.

Kunal Gandhi

7

7

2.

Dhara Shah

7

7

3.

Neha Thakore

3

3

4.

Baijoo Raval

7

5

5.

Karthik Iyer

5

4

6.

Radhika Shriram

1

1

15. Performance Evaluation

The Board of Directors, on the recommendation of the Nomination and Remuneration Committee, has adopted a Policy and criteria for evaluation of the Board, its Committees and Individual Directors. The performance of the Board and its Committees were evaluated after seeking inputs from all the Directors on the basis of criteria such as the composition and meetings, role & responsibilities and overall effectiveness of the Board & Committees. Evaluation of the performance of all Individual Directors (including Independent Directors and Chairperson) was also done during the year.

Pursuant to Schedule IV of the Act, the Independent Directors met on 12th February 2026, without the presence of Non-Independent Directors.

16. Remuneration Policy and Criteria for Appointment of Directors

The Nomination and Remuneration Policy of the Company provides roles and responsibilities of the Nomination and Remuneration Committee and the criteria for evaluation of the Board and compensation of the Directors and senior management. Further the assessment and appointment of members to the Board is based on a combination of criterion that includes ethics, personal and professional stature, domain expertise and specific qualification required for the position. The potential Independent Board member is also assessed on the basis of independence criteria defined in Section 149(6) of the Companies Act, 2013 and Regulation 16(1)(b) of the SEBI Listing Regulations.

In accordance with Section 178(3) of the Companies Act, 2013 and on recommendation of the Nomination and Remuneration Committee, the Board has adopted a policy including criteria for determining the qualification, positive attributes, independence and other matters for appointment and remuneration of Directors, Key Management Personnel and Senior Managerial Personnel. The said Policy is uploaded on the website of your Company at https://relictechnologies.in/ and is followed for respective appointment(s).

The remuneration paid to the directors is as per the terms laid out in the Nomination and Remuneration Policy of the Company.

17. Board Committees

In compliance with the Statutory requirements, the Company has constituted committees namely Audit Committee, Nomination and Remuneration Committee and Stakeholder Relationship Committee.

A. Audit Committee u/s 177 of the Act

The Audit Committee as on March 31,2026 comprises of Ms. Dhara Shah as the Chairperson and Ms. Neha Thakore, Mr. Kunal Gandhi as Members.

During the year under review, all recommendations made by the Audit Committee have been accepted by the Board. During the year, 4 meetings of the Committee were held.

B. Nomination and Remuneration Committee u/s 178 of the Act

The Nomination and Remuneration Committee as on March 31,2026 comprises of Ms. Dhara Shah as the Chairperson and Ms. Neha Thakore, Mr. Kunal Gandhi as Members. The Nomination and Remuneration Committee has adopted a remuneration policy as required under Section 178 of the Act. During the year, 5 meetings of the Committee were held.

The Remuneration Policy has been placed on the website of the Company and can be accessed through the following link - https://relictechnologies.in/

The salient features of the policy are as follows:

a) Nomination and Remuneration Committee (‘NRC’) identifies various traits of a person for appointment as Director/ KMP and recommends appointment to the Board.

b) Remuneration to Directors is decided by the Board on the basis of recommendations of the NRC.

c) Remuneration for Senior Management is decided on various industry parameters and performance matrix.

During the year, all recommendations made by the committee were approved by the Board.

C. Stakeholders Relationship Committee u/s 178 of the Act

The Stakeholders Relationship Committee as on March 31,2026 comprises of Ms. Dhara Shah as the Chairperson and Ms. Neha Thakore, Mr. Baijoo Raval as Members. During the year, 1 meeting of the _ Committee were held.

18. Risk Management

The Company has developed and implemented the risk management policy for the company.

The Company has established a robust risk management framework under the provisions of Companies Act, 2013. Under this framework, risks are identified across all business process of the Company on continuous basis. Once identified, they are managed systematically by categorizing them. It has been identified as one of the key enablers to achieve the Company’s objectives.

19. Directors’ Responsibility Statement

In terms of Section 134(5) of the Companies Act, 2013, your Directors state that:

a. in the preparation of the annual accounts for the FY 2025-26, the applicable accounting standards had been followed along with proper explanation relating to material departures, if any;

b. the directors have selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company for the financial year ended March 31,2026, and of the profit of the Company for that period;

c. the directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of this Act for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities;

d. the directors have prepared the annual accounts on a going concern basis;

e. the directors have devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively; and

f. the directors, had laid down internal financial controls to be followed by the Company and that such internal financial controls are adequate and were operating effectively;

20. Related Party Transactions

Your Company has formulated a Policy on Related Party Transactions in accordance with the provisions of Sections 177 and 188 of the Act and Rules made thereunder and the same is available on the website of your Company at https://relictechnologies.in/

None of the contract or arrangement or transaction with any of the Related Parties was in conflict with the interest of your Company. Since all the transactions with related parties during the year were on arm’s length basis and in the ordinary course of business, hence, the disclosure of related party transactions as required under Section 134(3)(h) of the Act in Form AOC-2 is not applicable to your Company for FY 2025-26.

Details of related party transactions entered into by your Company, in terms of Ind AS-24 have been disclosed in the Note 31 of the standalone and Note 37 of the consolidated financial statements, respectively, forming part of this Report.

21. Vigil Mechanism/ Whistle Blower Policy

The Company has Whistle-Blower Policy (Whistle-Blower/ Vigil Mechanism) to report concerns. Under this policy, provisions have been made to safeguard persons who use this mechanism from victimization.

The policy also provides access to the chairperson of the Audit Committee under certain circumstances. The said Policy is also available on the Company’s website https://relictechnologies.in/.

None of the persons/Whistle Blower was denied access to the Audit Committee during the year.

22. Auditors

A. Statutory Auditors

M/s. D. Kothary & Co., (FRN 105335W), Chartered Accountants, were appointed as Statutory Auditors of the Company at the Thirty Fourth Annual General Meeting held on 29th August 2025, to hold office for a term of 5 (five) consecutive years till the conclusion of the 39th Annual General Meeting to be held in respect of F.Y. 2030-31.

The report of the Statutory Auditors forms part of the Annual Report for FY 2024-25. The said report does not contain any qualification, reservation, adverse remark or disclaimer.

B. Secretarial Auditors

Pursuant to Section 204 of the Companies Act, 2013 and the Companies (Appointment & Remuneration of Managerial Personnel) Rules, 2014, M/s. Vibhuti Dani and Associates, Practicing Company Secretaries (Membership No. 7453, Certificate of Practice 26505) were appointed to conduct the Secretarial Audit of the Company for Financial Year 2025-2026. The Secretarial Audit Report for FY 2025-26 is attached as “Annexure-II”.

23. Board’s Response on Auditors Qualification, Reservation or Adverse Remark

• There are no qualifications, reservations or adverse remarks made by the Statutory Auditors, in their Report for the financial year ended March 31,2026. The Report is enclosed with financial statements in this Annual Report.

• There are no qualifications, reservations or adverse remarks made by the Secretarial Auditors, in their Report for the financial year ended March 31,2026.

24. Reporting of Frauds

Pursuant to provisions of the Section 143(12) of the Companies Act, 2013, neither the Statutory Auditors nor the Secretarial Auditor has reported any incident of fraud during the year under review.

25. Significant and Material Orders Passed by the Courts/Regulators

During FY 2025-26, there were no significant and/or material orders, passed by any Court or Regulator or Tribunal, which may impact the going concern status or the Company’s operations in future.

26. Corporate Social Responsibility

Based on the applicable provisions, Corporate Social Responsibility under Section 135 is not applicable to the Company during FY 2025-26.

Therefore, there is no requirement of providing Annual Report on CSR activities, in terms of Section 13 of the Act and the Rules framed thereunder.

27. Information Required Under Sexual Harassment of Women at Workplace (Prevention, Prohibition & Redressal) Act, 2013

The Company is committed to providing a safe, secure and respectful work environment free from sexual harassment. The Company has complied with the applicable provisions of the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 (“POSH Act”) and the rules made thereunder.

As the Company had less than ten employees during the Financial Year 2025-26, the constitution of an Internal Committee under the provisions of the POSH Act was not applicable.

During the Financial Year 2025-26, no complaints relating to sexual harassment were received. The details are as under:

Particulars Details

Number of Complaints received during FY 2025-26 NIL

Number of Complaints disposed during FY 2025-26 NIL

Number of Complaints pending for more than 90 days NIL

Nature of Action taken by the District Officer Not Applicable

28. Secretarial Standards

The Directors state that applicable Secretarial Standards i.e. SS-1 and SS-2, relating to ‘Meeting of Board of Directors’ and ‘General Meetings’ respectively have been duly complied by the Company.

29. Particulars of Employees

Disclosures pertaining to remuneration and other details as required under Section 197(12) of the Act, read with Rule 5(1) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, are attached as Annexure III forming part of this Report.

In terms of Section 197(12) of the Act, read with Rule 5(2) and 5(3) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, there were no employees drawing remuneration in __excess of limits set out in said rules.

30. Conservation of Energy, Research and Development, Technology Absorption, Foreign Exchange Earnings and Outgo

(A) CONSERVATION OF ENERGY-

a.

The steps taken or impact on conservation

The Company is engaged in pharma / wellness

of energy;

products’ distribution trading of medicines, etc., which requires very minimum amount

b.

The steps taken by the company for utilising

of energy. However, the Company has taken

alternate sources of energy;

measures to reduce energy consumption, wherever possible.

c.

The capital investment on energy conservation equipments;

(R) TFCHNOIOGY ARSORPTION -

(a)

The efforts made towards technology absorption

No new technology has been absorbed during the financial year.

The benefits derived like product improvement, cost reduction, product development or import substitution.

N.A.

In case of imported technology (imported

during the last three years reckoned from the

beginning of the

financial year)-

i. the details of technology imported

ii. the year of import

iii. whether the technology been fully absorbed

iv. if not fully absorbed, areas where absorption has not taken place, and the reasons thereof

No new technology has been imported during the last three years.

The expenditure incurred on Research and Development.

NIL

(C) FOREIGN EXCHANGE EARNINGS AND OUTGO-

During the year under review, total Foreign Exchange Earnings and Outgo on actual inflow and outflow basis, is as under: NII

Particulars

FY 2025-26

FY 2024-25

Foreign Exchange Earning

-

-

Expenditure in Foreign Exchange

-

-

31. Copy of Annual Return

Pursuant to Section 92(3) and Section 134(3)(a) of the Companies Act, 2013, the Company will place a copy of the Annual Return as of March 31,2026, on its website at https://relictechnologies.in/

32. DISCLOSURES

Your Directors state that for the Financial Year 2025-26, disclosures in respect of the certain items were not required and accordingly affirm as under:

• The Company has not accepted any deposits and hence details relating to deposits covered under Chapter V of the Act are not applicable to the Company;

• There were no material changes and commitments affecting the financial position of the Company between the end of the financial year and the date of this report.

• The provisions relating to maintenance of cost records under sub section (1) of Section 148 of the Companies Act, 2013 are not applicable on the Company during the financial year.

• No amount or Shares were required to be transferred to the Investor Education and Protection Fund under the provisions of the Act.

• Your Company has not issued shares with differential voting rights and sweat equity shares during the year under review.

• No Buyback of shares was undertaken by the Company during FY 2025-26.

• There were no instances where your Company required the valuation for one-time settlement or while taking the loan from the Banks or Financial Institutions.

• No petition/application has been admitted against the Company, under Insolvency and Bankruptcy Code, 2016, by the National Company Law Tribunal.

• During the FY 2025-26, except Mr. Karthik Iyer, Executive Director, who received remuneration from the Subsidiary Company as well, no other Whole Time Director of the Company received any remuneration or commission from any of the Subsidiaries of the Company.

• The Company has software for maintaining its books of account and has a feature of recording audit trail for each transaction with audit log.

• The provisions of the Maternity Benefit Act, 1961 are not applicable to the Company during the year.

33. Acknowledgement

We thank our customers, vendors, investors, bankers, employees, for their continued support during the

year. We place on record our appreciation for the contribution made by our employees at all levels. We

further place on record their sincere appreciation for the assistance and co-operation received from Financial

Institutions, Banks, Government Authorities and Business Partners.